Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink, Lodewijk A.A. Brosens, Vikram Deshpande, Charles B. Epstein, Elfi B. Conemans, Folkert H.M. Morsink, Mindy K. Graham, Gerlof D. Valk, Menno R. Vriens, Carlos Fernandez del Castillo, Cristina R. Ferrone, Tomer Adar, Michaela Bowden, Holly J. Whitton, Annacarolina Da Silva, Alba Font-Tello, Henry W. Long, Elizabeth GaskellNoam Shoresh, Christopher M. Heaphy, Ewa Sicinska, Matthew H. Kulke, Daniel C. Chung, Bradley E. Bernstein, Ramesh A. Shivdasani*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original languageAmerican English
Pages (from-to)1627
Number of pages1
JournalNature Medicine
Volume25
Issue number10
DOIs
StatePublished - 1 Oct 2019

Bibliographical note

Publisher Copyright:
© 2019, Springer Nature America, Inc.

Fingerprint

Dive into the research topics of 'Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)'. Together they form a unique fingerprint.

Cite this